FFO
CORZ icon

Fortitude Family Office’s Core Scientific CORZ Stock Holding History

Fortitude Family Office’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53K Buy
99
+50
+102% +$1.18K ﹤0.01% 1394
2026
Q1 		$733 Buy
+49
New +$836 ﹤0.01% 1590

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Fortitude Family Office's CORZ Position: Q2 2026 in Review

Fortitude Family Office increased its Core Scientific (CORZ) stake by 102% in Q2 2026, buying an estimated $1.18K and bringing the position to 99 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1394.

Fortitude Family Office first reported a position in CORZ in Q1 2026 and has held it in 2 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Fortitude Family Office held 99 shares of Core Scientific worth $2.53K as of Q2 2026.
  • Fortitude Family Office bought 50 Core Scientific shares in Q2 2026, an estimated $1.18K.
  • Core Scientific made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1394 holding.
  • Fortitude Family Office first reported a position in Core Scientific in Q1 2026 and has held it in 2 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.